{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-130486","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2023-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.903119+00:00","generated_at":"2026-06-07T05:47:01.674935+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CFO Anthony Rimac to resign Jan. 31, 2024; interim appointments from Stout","bullets":["CFO Anthony Rimac resigns effective Jan. 31, 2024 for personal reasons; no disagreement with company or auditors.","Stout's Gaeton Biscardi named Interim VP of Finance; Joe Oriti to serve as consultant and likely Interim Principal Financial Officer.","Board intends to appoint Oriti as Interim PFO and will conduct a search for a permanent CFO."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-130486","json":"https://secwatch.observer/filing/0001104659-23-130486.json","markdown":"https://secwatch.observer/filing/0001104659-23-130486.md","text":"https://secwatch.observer/filing/0001104659-23-130486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/tm2333876d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T05:47:01.674935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0bd3fda8bc","claim":"Anthony Rimac resigned as Chief Financial Officer at Sagimet Biosciences Inc..","evidence_excerpt":"Anthony Rimac provided notice of his intent to step down as the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) effective January 31, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"659f286008","claim":"Gaeton Biscardi was appointed as Interim VP of Finance at Sagimet Biosciences Inc..","evidence_excerpt":"Gaeton Biscardi, Managing Director of Stout, will be serving as the Company’s Interim VP of Finance during this transition period","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim VP of Finance"}],"fact_type":"executive_change"},{"claim_id":"da310e0cf8","claim":"Joe Oriti was appointed as Interim Principal Financial Officer at Sagimet Biosciences Inc..","evidence_excerpt":"the Company intends to appoint Mr. Oriti as Interim Principal Financial Officer of the Company following Mr. Rimac’s departure","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465923130486/0001104659-23-130486-index.htm","confidence":0.85,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}